We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

188 hedge funds and large institutions have $1.31B invested in Coherus Oncology in 2019 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 69 increasing their positions, 49 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 18

87% more call options, than puts

Call options by funds: $8.76M | Put options by funds: $4.67M

41% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 49

13% more funds holding

Funds holding: 167 → 188 (+21)

4.25% more ownership

Funds ownership: 99.43% → 103.68% (+4.3%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

7% less capital invested

Capital invested by funds: $1.41B → $1.31B (-$96.2M)

Holders
188
Holders Change
+21
Holders Change %
+12.57%
% of All Funds
3.7%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
46
Increased
69
Reduced
49
Closed
18
Calls
$8.76M
Puts
$4.67M
Net Calls
+$4.09M
Net Calls Change
-$6.73M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$29.9M
2
Ameriprise
Ameriprise
Minnesota
+$16.1M
3
Temasek Holdings
Temasek Holdings
Singapore
+$15.2M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$13.4M
5
State Street
State Street
Massachusetts
+$13M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$79.1M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$42.8M
3
DM
Deerfield Management
New York
-$31.2M
4
Invesco
Invesco
Georgia
-$7.8M
5
Citadel Advisors
Citadel Advisors
Florida
-$7.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
HIM
101
Hillsdale Investment Management
Ontario, Canada
$835K +$856K +46,400 New
CSS
102
Cubist Systematic Strategies
Connecticut
$818K +$325K +17,603 +63%
Envestnet Asset Management
103
Envestnet Asset Management
Illinois
$813K +$45.7K +2,476 +6%
VOYA Investment Management
104
VOYA Investment Management
Georgia
$808K +$382K +20,701 +86%
Citigroup
105
Citigroup
New York
$780K -$816K -44,229 -51%
GCP
106
GSA Capital Partners
United Kingdom
$773K +$537K +29,122 +211%
Bank of America
107
Bank of America
North Carolina
$762K -$321K -17,392 -29%
Hudson Bay Capital Management
108
Hudson Bay Capital Management
Connecticut
$726K +$744K +40,340 New
AIG
109
American International Group
New York
$706K +$1.84K +100 +0.3%
OAM
110
Oberweis Asset Management
Illinois
$677K +$693K +37,600 New
AQR Capital Management
111
AQR Capital Management
Connecticut
$670K +$355K +19,254 +107%
Manulife (Manufacturers Life Insurance)
112
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$669K -$22.8K -1,236 -3%
Russell Investments Group
113
Russell Investments Group
United Kingdom
$662K -$1.17M -63,204 -63%
RCM
114
Requisite Capital Management
Texas
$630K +$645K +35,000 New
UBS Group
115
UBS Group
Switzerland
$550K -$50.2K -2,722 -8%
AG
116
Algert Global
California
$535K -$863K -46,769 -61%
WAM
117
Wakefield Asset Management
Colorado
$535K +$548K +29,710 New
Allianz Asset Management
118
Allianz Asset Management
Germany
$525K -$2.53K -137 -0.5%
MIM
119
MetLife Investment Management
New Jersey
$511K – – –
ASN
120
Advisory Services Network
Georgia
$494K +$506K +27,455 New
SEI Investments
121
SEI Investments
Pennsylvania
$477K -$131K -7,116 -21%
State Board of Administration of Florida Retirement System
122
State Board of Administration of Florida Retirement System
Florida
$459K – – –
BCM
123
Bluefin Capital Management
New York
$456K +$467K +25,339 New
KSCM
124
Kamunting Street Capital Management
Florida
$450K +$461K +25,000 New
Nisa Investment Advisors
125
Nisa Investment Advisors
Missouri
$446K – – –
3 4
5
6 7

CHRS Hedge Fund Activity: Q4 2019 in Review

188 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q4 2019, worth a combined $1.31B — down 6.8% from $1.41B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new CHRS positions and 18 closed out — a net gain of 28 holders — while 69 added to existing stakes and 49 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $29.9M. The largest seller was Wellington Management Group, cutting an estimated $79.1M.

  • 188 institutional investors held Coherus Oncology (CHRS) as of Q4 2019, up from 167 in Q3 2019.
  • Funds reported $1.31B of Coherus Oncology stock for Q4 2019, down 6.8% quarter-over-quarter.
  • 46 funds opened new Coherus Oncology positions in Q4 2019 and 18 closed out, a net change of +28 holders.
  • The largest Coherus Oncology buyer in Q4 2019 was AllianceBernstein, an estimated $29.9M added.
  • The largest Coherus Oncology seller in Q4 2019 was Wellington Management Group, an estimated $79.1M sold.

Based on aggregated 13F filings for Q4 2019.